These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3240242)

  • 1. Achondroplasia: an altered GH control in post-receptorial chondrocyte cell sites?
    Borrelli P; del Balzo P; Neri E
    Basic Life Sci; 1988; 48():135-41. PubMed ID: 3240242
    [No Abstract]   [Full Text] [Related]  

  • 2. Growth hormone therapy in achondroplasia.
    Seino Y; Yamanaka Y; Shinohara M; Ikegami S; Koike M; Miyazawa M; Inoue M; Moriwake T; Tanaka H
    Horm Res; 2000; 53 Suppl 3():53-6. PubMed ID: 10971105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth-promoting effect of human growth hormone on patients with achondroplasia.
    Okabe T; Nishikawa K; Miyamori C; Sato T
    Acta Paediatr Jpn; 1991 Jun; 33(3):357-62. PubMed ID: 1785332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone therapy in achondroplasia.
    Nishi Y; Kajiyama M; Miyagawa S; Fujiwara M; Hamamoto K
    Acta Endocrinol (Copenh); 1993 May; 128(5):394-6. PubMed ID: 8317186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Final adult height in long-term growth hormone-treated achondroplasia patients.
    Harada D; Namba N; Hanioka Y; Ueyama K; Sakamoto N; Nakano Y; Izui M; Nagamatsu Y; Kashiwagi H; Yamamuro M; Ishiura Y; Ogitani A; Seino Y
    Eur J Pediatr; 2017 Jul; 176(7):873-879. PubMed ID: 28501952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of growth hormone therapy for patients with skeletal dysplasia.
    Kanazawa H; Tanaka H; Inoue M; Yamanaka Y; Namba N; Seino Y
    J Bone Miner Metab; 2003; 21(5):307-10. PubMed ID: 12928832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth and growth hormone therapy in children with achondroplasia: a two-year experience.
    Stamoyannou L; Karachaliou F; Neou P; Papataxiarchou K; Pistevos G; Bartsocas CS
    Am J Med Genet; 1997 Oct; 72(1):71-6. PubMed ID: 9295079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human growth hormone treatment in prepubertal children with achondroplasia.
    Weber G; Prinster C; Meneghel M; Russo F; Mora S; Puzzovio M; Del Maschio M; Chiumello G
    Am J Med Genet; 1996 Feb; 61(4):396-400. PubMed ID: 8834055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone therapy in achondroplasia.
    Horton WA; Hecht JT; Hood OJ; Marshall RN; Moore WV; Hollowell JG
    Am J Med Genet; 1992 Mar; 42(5):667-70. PubMed ID: 1632435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pituitary dwarfism. Evaluation of our cases].
    Bartolotta E; Giacomozzi E; Migliori C; Conti S
    Minerva Med; 1982 May; 73(20):1421-4. PubMed ID: 7078818
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of the administration of norandrostenolone phenylpropionate on growth cartilage in human achondroplasia].
    Stănesco V; Bona C; Ionesco V; Duca D
    Rev Fr Etud Clin Biol; 1968; 13(7):709-12. PubMed ID: 4177894
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of growth hormone dose on bone maturation and puberty in children with idiopathic short stature.
    Crowe BJ; Rekers-Mombarg LT; Robling K; Wolka AM; Cutler GB; Wit JM;
    J Clin Endocrinol Metab; 2006 Jan; 91(1):169-75. PubMed ID: 16263828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term recombinant human growth hormone treatment increases growth rate in achondroplasia.
    Shohat M; Tick D; Barakat S; Bu X; Melmed S; Rimoin DL
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4033-7. PubMed ID: 8923856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic benefit of growth hormone in achrondroplastic dwarfism.
    Kodama H; Okabe I; Yanagisawa M
    Acta Paediatr Jpn; 1990 Jun; 32(3):323-4. PubMed ID: 2239308
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum NT-proCNP levels increased after initiation of GH treatment in patients with achondroplasia/hypochondroplasia.
    Kubota T; Wang W; Miura K; Nakayama H; Yamamoto K; Fujiwara M; Ohata Y; Tachibana M; Kitaoka T; Takakuwa S; Miyoshi Y; Namba N; Ozono K
    Clin Endocrinol (Oxf); 2016 Jun; 84(6):845-50. PubMed ID: 26814021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress report: growth hormone in skeletal dysplasia.
    Bridges NA; Brook CG
    Horm Res; 1994; 42(4-5):231-4. PubMed ID: 7868078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comparison of the effects of short-term growth hormone treatment in patients with achondroplasia and with hypochondroplasia.
    Tanaka N; Katsumata N; Horikawa R; Tanaka T
    Endocr J; 2003 Feb; 50(1):69-75. PubMed ID: 12733711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-conventional use of growth hormone therapy.
    Cappa M; Ubertini G; Colabianchi D; Fiori R; Cambiaso P
    Acta Paediatr Suppl; 2006 Jul; 95(452):9-13. PubMed ID: 16801158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative action of human growth hormone and synthetic anabolics on the growth rate in hypothalamo-hypophyseal dwarfism].
    Royer P; Rappaport R; Elsair J; Ciric S; Cachin O
    Ann Endocrinol (Paris); 1970; 31(1):121-30. PubMed ID: 4314692
    [No Abstract]   [Full Text] [Related]  

  • 20. Growth Hormone Treatment for Achondroplasia.
    Yorifuji T; Higuchi S; Kawakita R
    Pediatr Endocrinol Rev; 2018 Sep; 16(Suppl 1):123-128. PubMed ID: 30378790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.